BioCardia, Inc.
BCDA
$0.88
$0.0810.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.24M | 1.13M | 936.00K | 1.37M | 1.53M |
| Gross Profit | -1.24M | -1.13M | -936.00K | -1.37M | -1.53M |
| SG&A Expenses | 1.03M | 885.00K | 552.00K | 683.00K | 1.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.27M | 2.01M | 1.49M | 2.05M | 2.73M |
| Operating Income | -2.27M | -2.01M | -1.49M | -2.05M | -2.73M |
| Income Before Tax | -2.26M | -1.98M | -1.48M | -2.05M | -2.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.26M | -1.98M | -1.48M | -2.05M | -2.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.26M | -1.98M | -1.48M | -2.05M | -2.71M |
| EBIT | -2.27M | -2.01M | -1.49M | -2.05M | -2.73M |
| EBITDA | -2.26M | -2.01M | -1.48M | -2.05M | -2.71M |
| EPS Basic | -0.21 | -0.19 | -0.24 | -0.41 | -0.59 |
| Normalized Basic EPS | -0.13 | -0.12 | -0.15 | -0.25 | -0.37 |
| EPS Diluted | -0.21 | -0.19 | -0.24 | -0.41 | -0.59 |
| Normalized Diluted EPS | -0.13 | -0.12 | -0.15 | -0.25 | -0.37 |
| Average Basic Shares Outstanding | 10.81M | 10.68M | 6.28M | 5.06M | 4.64M |
| Average Diluted Shares Outstanding | 10.81M | 10.68M | 6.28M | 5.06M | 4.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |